AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.8640
+0.0419 (5.10%)
At close: Dec 15, 2025, 4:00 PM EST
0.8595
-0.0045 (-0.52%)
After-hours: Dec 15, 2025, 5:17 PM EST
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $10.23 million as of December 15, 2025. Its market cap has decreased by -53.83% in one year.
Market Cap
10.23M
Enterprise Value
22.06M
1-Year Change
-53.83%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $10.23M, a decrease of -83.93%. That is a compound annual growth rate of -32.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 9.73M | -54.91% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | 63.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |